The limitations of locus specific methylation qualification and quantification in clinical material

Frontiers in Genetics

Volumn 3, Issue FEB, 2012, Pages

  Wojdacz, Tomasz K ^a,b,c  

^a Lundbeck Foundation Centre for International Research in Radiation Oncology   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Cancer; Methylation; MIP; MSP; Qualification; Quantification

Indexed keywords

EID: 84876057826     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2012.00021     Document Type: Article

References (27)

1. Aggerholm, A., and Hokland, P. (2000). DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology? Blood 95, 2997-2999.
2. Balic, M., Pichler, M., Strutz, J., Heitzer, E., Ausch, C., Samonigg, H., Cote, R. J., and Dandachi, N. (2009). High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis. J. Mol. Diagn. 11, 102-108.
3. Candiloro, I. L., Mikeska, T., and Dobrovic, A. (2011). Assessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation. Epigenetics 6, 500-507.
4. Clark, S. J., Harrison, J., Paul, C. L., and Frommer, M. (1994). High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 22, 2990-2997.
5. Eads, C. A., Danenberg, K. D., Kawakami, K., Saltz, L. B., Blake, C., Shibata, D., Danenberg, P. V., and Laird, P. W. (2000). MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 28, E32.
6. Esteller, M. (2008). Epigenetics in cancer. N. Engl. J. Med. 358, 1148-1159.
7. Fazzari, M. J., and Greally, J. M. (2010). Introduction to epigenomics and epigenome-wide analysis. Methods Mol. Biol. 620, 243-265.
8. Harden, S. V., Sanderson, H., Goodman, S. N., Partin, A. A., Walsh, P. C., Epstein, J. I., and Sidransky, D. (2003). Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies. J. Natl. Cancer Inst. 95, 1634-1637.
9. Hegi, M. E., Diserens, A. C., Gorlia, T., Hamou, M. F., De Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., Bromberg, J. E., Hau, P., Mirimanoff, R. O., Cairncross, J. G., Janzer, R. C., and Stupp, R. (2005). MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352, 997-1003.
10. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U.S.A. 93, 9821-9826.
11. Mikeska, T., Candiloro, I. L., and Dobrovic, A. (2010). The implications of heterogeneous DNA methylation for the accurate quantification of methylation. Epigenomics 2, 561-573.
12. Oster, B., Thorsen, K., Lamy, P., Wojdacz, T. K., Hansen, L. L., Birkenkamp-Demtroder, K., Sorensen, K. D., Laurberg, S., Orntoft, T. F., and Andersen, C. L. (2011). Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. Int. J. Cancer 129, 2855-2866.
13. Reinert, T., Modin, C., Castano, F. M., Lamy, P., Wojdacz, T. K., Hansen, L. L., Wiuf, C., Borre, M., Dyrskjot, L., and Orntoft, T. F. (2011). Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers. Clin. Cancer Res. 17, 5582-5592.
14. Stanzer, S., Balic, M., Strutz, J., Heitzer, E., Obermair, F., Hauser-Kronberger, C., Samonigg, H., and Dandachi, N. (2010). Rapid and reliable detection of LINE-1 hypomethylation using high-resolution melting analysis. Clin. Biochem. 43, 1443-1448.
15. Trinh, B. N., Long, T. I., and Laird, P. W. (2001). DNA methylation analysis by MethyLight technology. Methods 25, 456-462.
16. Wallace, K., Grau, M. V., Levine, A. J., Shen, L., Hamdan, R., Chen, X., Gui, J., Haile, R. W., Barry, E. L., Ahnen, D., Mckeown-Eyssen, G., Baron, J. A., and Issa, J. P. (2010). Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer Prev. Res. (Phila.) 3, 1552-1564.
17. Warnecke, P. M., Stirzaker, C., Melki, J. R., Millar, D. S., Paul, C. L., and Clark, S. J. (1997). Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. Nucleic Acids Res. 25, 4422-4426.
18. Wojdacz, T. K., Borgbo, T., and Hansen, L. L. (2009). Primer design versus PCR bias in methylation independent PCR amplifications. Epigenetics 4, 231-234.
19. Wojdacz, T. K., and Dobrovic, A. (2007). Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res. 35, e41.
20. Wojdacz, T. K., Dobrovic, A., and Algar, E. M. (2008a). Rapid detection of methylation change at H19 in human imprinting disorders using methylation-sensitive high-resolution melting. Hum. Mutat. 29, 1255-1260.
21. Wojdacz, T. K., Dobrovic, A., and Hansen, L. L. (2008b). Methylation-sensitive high-resolution melting. Nat. Protoc. 3, 1903-1908.
22. Wojdacz, T. K., Hansen, L. L., and Dobrovic, A. (2008c). A new approach to primer design for the control of PCR bias in methylation studies. BMC Res. Notes 1, 54.
23. Wojdacz, T. K., and Hansen, L. L. (2006). Techniques used in studies of age-related DNA methylation changes. Ann. N. Y. Acad. Sci. 1067, 479-487.
24. Wojdacz, T. K., Moller, T. H., Thestrup, B. B., Kristensen, L. S., and Hansen, L. L. (2010). Limitations and advantages of MS-HRM and bisulfite sequencing for single locus methylation studies. Expert Rev. Mol. Diagn. 10, 575-580.
25. Wojdacz, T. K., Thestrup, B. B., Cold, S., Overgaard, J., and Hansen, L. L. (2011a). No difference in the frequency of locus-specific methylation in the peripheral blood DNA of women diagnosed with breast cancer and age-matched controls. Future Oncol. 7, 1451-1455.
26. Wojdacz, T. K., Thestrup, B. B., Overgaard, J., and Hansen, L. L. (2011b). Methylation of cancer related genes in tumor and peripheral blood DNA from the same breast cancer patient as two independent events. Diagn. Pathol. 6, 116.
27. Xiong, Z., and Laird, P. W. (1997). COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 25, 2532-2534